Sponsor: 
Merck Sharp & Dohme (Australia)
Administration route: 
Oral
Vaccine group: 
Rotavirus vaccines

Registered for use in infants, with an upper age limit for dose 3 of 32 weeks.

Live attenuated pentavalent human–bovine reassortant rotavirus vaccine

Each 2.0 mL monodose pre-filled dosing tube contains:

  • a minimum dose level of at least 2.0 x 106 infectious units of each of the rotavirus reassortants G1, G2, G3, G4 and P1A[8] derived from rotaviruses infecting human and bovine species
  • sodium citrate
  • sodium phosphate monobasic monohydrate
  • sodium hydroxide
  • polysorbate 80
  • cell culture medium

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018